PhRMA director of public affairs on 340B exploitation: ‘Evidence shows that 340B entities markup medicines by as much 1,000% or more’
HealthLeaders editor on 340B: ‘We continue to have serious concerns about persistent and often illegal abuse of 340B’
PhRMA senior director on 340B program: 'Hospitals abuse the program to boost their profits at the expense of patients'
Iowa board files charges against FarmaKeio, citing FDA and California actions
Pharmacy license expiry extended due to payment issues
Alerts Sign-up
